ATRICURE

An estimated 8 million people have atrial fibrillation (Afib, AF) in the U.S. 1 The FDA recently approved Hybrid AF TM Therapy as a safe and effective option to treat the over 3.5 million people with long-standing persistent Afib. Nearly 2x more effective than existing therapy options, Hybrid AF Therapy offers new hope for patients with long-standing persistent atrial fibrillation... A new treatment for atrial fibrillation offers hope for patients with long-standing persistent Afib. Learn more about Hybrid AF™ Therapy.

Also known as: Atricure, Inc.

Primary location: Mason United States